产品说明书
RCM-1
 |
同义名 : | Robert Costa Memorial drug-1 |
| CAS号 : | 339163-65-4 | |
| 货号 : | A1166728 | |
| 分子式 : | C20H12N2OS4 | |
| 纯度 : | 98% | |
| 分子量 : | 424.582 | |
| MDL号 : | MFCD00742440 | |
| 存储条件： |
粉末 Keep in dark place,Inert atmosphere,Room temperature 液体 -20°C:3-6个月-80°C:12个月 |
|
| 溶解度 : |
DMSO: 16 mg/mL(37.68 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO |
|
| 动物实验配方： |
| 生物活性 | |||
|---|---|---|---|
| 描述 | FOXM1 is a transcription factor from the Forkhead box (FOX) family that is critical for the differentiation of goblet cells from airway progenitor cells. RCM-1 is a FOXM1 inhibitor which inhibits goblet cell metaplasia and IL-13 signaling, and RCM-1 is used to treat patients with asthma and other chronic airway diseases. RCM-1 inhibited GFP-FOXM1 with an EC50 of 0.72 μM in U2OS cells. Furthermore, RCM-1 inhibited the expression of FOXM1 target genes Plk1 and Cdc25B, a functional readout of FOXM1 transcriptional activity. In addition to GFP-FOXM1, RCM-1 decreased the abundance of endogenous FOXM1 in primary human airway epithelial cells cultured on an air-liquid interface without altering that of other transcription factors. In vivo, RCM-1 treatment decreased the abundance of endogenous FOXM1 in wild-type BALB/c mice. RCM-1 protected lungs from HDM-induced airway hyperreactivity and preserved lung function in BALB/c mice. Moreover, RCM-1 decreased goblet cell metaplasia and airway resistance and improved lung function in IL-13-treated mice[2]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.36mL 0.47mL 0.24mL |
11.78mL 2.36mL 1.18mL |
23.55mL 4.71mL 2.36mL |
| 参考文献 |
|---|